Cannabigerol (CBG) is a non-intoxicating cannabinoid found in the cannabis plant that serves as a precursor to major cannabinoids such as CBD and THC. In this 2022 scientific review, researchers examined the pharmacological properties of CBG and its synthetic derivatives, highlighting evidence that CBG interacts with multiple biological targets involved in inflammation, pain signaling, neurological […]
Tag: antibacterial
Cannabigerol (CBG) Derivatives Show Strong Antibacterial Activity Against Gram-Positive Bacteria (pub. March 2026)
As antibiotic resistance continues to rise, researchers are exploring how modifying natural compounds like cannabigerol (CBG) can enhance their antibacterial effects. This study examined the structure–activity relationships (SAR) of CBG and its precursor cannabigerolic acid (CBGA) to understand how changes in their chemical structure impact their ability to fight Gram-positive bacteria. Scientists tested a range […]
CBD and Other Cannabinoids Show Antibacterial Activity Against Drug-Resistant Enterococcus Strain (pub. Jan 2026)
As antibiotic resistance continues to grow worldwide, researchers are exploring plant-derived compounds as potential new antibacterial tools. This pilot study investigated whether cannabidiol (CBD) and cannabinoid-based preparations could inhibit clinical strains of Enterococcus faecalis and Enterococcus faecium, two bacteria commonly associated with hospital-acquired infections and known for developing resistance to conventional antibiotics. Scientists compared purified […]